| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $909.2M | -0.1% |
| Cost of Revenue | $261.1M | -5.8% |
| Gross Profit | $648.0M | +2.3% |
| R&D Expense | $149.3M | +11.6% |
| SG&A Expense | $379.6M | -6.5% |
| Operating Income | $106.4M | +56.0% |
| Pre-tax Income | $98.3M | +60.5% |
| Income Tax | $15.2M | -29.5% |
| Net Income | $82.3M | +113.1% |
| EPS (Basic) | $1.05 | +275.0% |
| EPS (Diluted) | $1.04 | +271.4% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215.7M | -10.6% |
| Accounts Receivable | $203.1M | +6.6% |
| Inventory | $14.3M | +0.7% |
| Current Assets | $578.8M | +1.0% |
| Total Assets | $2.29B | +2.9% |
| Current Liabilities | $518.7M | +24.0% |
| Long-term Debt | $412.8M | +0.4% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $157.4M | +4.5% |
| Capital Expenditures | $15.3M | -4.8% |
| Investing Cash Flow | -$84.0M | -124.8% |
| Financing Cash Flow | -$99.7M | +35.0% |
| Free Cash Flow | $142.1M | +5.6% |
| Total Liabilities |
| $964.5M |
| +0.7% |
| Stockholders' Equity | $886.8M | +6.8% |